Abstract:Background and Aims: Current cardiovascular disease (CVD) prevention is based on diagnosis and treatment of specific disease. Little is known for high risk people with CVD at the community level. In rural China, health records of all residents were established after the recent health reforms. This study aims to describe the characters of the rural population with high CVD risk regarding their clinical indicators, disease patterns, drug treatment and adherence.Methods and Results: 17042 (87%) of all the 19500 rural residents in the two townships had valid health records in 2009. We employed a validated tool, the Asian Equation, to screen 8182 (48%) resident health records of those aged between 40-75 years in 2010. Those who were identified with a CVD risk of 20% or higher were selected for a face-to-face questionnaire survey regarding their diagnosed disease and drug treatment. 453 individuals were identified as high risk of CVD, with an average age of 53 years, 62% males, 50% smoking rate and average systolic blood pressure of 161 mmHg. 386 (85%) participated in the survey, while 294 (76%) were diagnosed with and 88 (23%) were suspects of CVD, hypertension, diabetes or hyperlipidaemia. 75 (19%) took drug regularly and 125 (32%) either stopped treatment or missed drugs. The most often used drugs were calcium channel blockers (20%). Only 2% used aspirins and 0.8% used statins. The median costs of drugs were 17 RMB (USD2.66) per month.Conclusion: The majority of the high risk population in our setting of rural China had already been diagnosed with a CVD related disease, but very few took any drugs, and less still took highly effective drugs to prevent CVD. A holistic strategy focused on population with high risk CVD and based on the current China public health reform is suggested in the context of primary care.

Thinking on the prevention,treatment and patient rehabilitation of cardiovascular disease in China

To Apply the Scientific Outlook on Development,Lead Healthy Chinese and Create a New Situation in China’s Cardiovascular Disease Prevention and Control

Achieving cardiovascular health in China:we should take overall balance to maitain sustainable development in acccount

Leading Prevention and Treatment of Cardiovascular Disease with Scientific Evidence and Management

[The construction of comprehensive stroke prevention and control system requires attention to the precise policies of young stroke].

Characteristics of High Risk People with Cardiovascular Disease in Chinese Rural Areas: Clinical Indictors, Disease Patterns and Drug Treatment

Exploration of Chinese style management for stroke prevention and treatment

Cardiovascular Diseases in China: Current Status and Future Perspectives

Prevention and Control Strategy of Coronary Heart Disease in China

The Development of Cardiac Rehabilitation in China: Current Status and Future Perspectives

Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?

Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China

Review of Cardiovascular Disease Prevention and Control Programs: International Experience and Challenges in China

Thoughts and practice on the development of cardiovascular discipline in county hospitals in China

Stroke Prevention and Control in China:Achievements, Challenges and Responses

Establishing an Innovation-Oriented National Preventive Medicine System in China

The status quo of Chinese prevention and treatment of dyslipidemia

Investigation on promoting appropriate prevention and treatment technology of cardiology in rural areas of Henan

Report on Cardiovascular Health and Diseases in China 2023: An Updated Summary

Early Diagnosis and Strategy for Prevention and Treatment of Coronary Artery Disease

Preventing chronic diseases in China.